Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

11 Jan 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30635808
DOI: 10.1007/s10549-018-05127-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patientsPMID 30635808Read ↗

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapySemantic proximity Read ↗

Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma familiesSemantic proximity Read ↗

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSemantic proximity Read ↗

Breast cancer and BRCA1 mutations.Semantic proximity Read ↗

The influence of BRCA1/BRCA2 mutations on toxicity related to chemotherapy and radiotherapy in early breast cancer patients.Semantic proximity Read ↗

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern ItalySemantic proximity Read ↗

BRCA2 mutation and the risk of hematologic malignancy.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patientsSemantic proximity Read ↗

BRCA1 and BRCA2 in breast cancer.Semantic proximity Read ↗

BRCA gene mutations and cancer.Semantic proximity Read ↗

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1Semantic proximity Read ↗

Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.